O5 Adoption Leads to Bullish Views Around Insulet Corporation (PODD)
On February 4, Stifel lowered its price target on Insulet Corporation (NASDAQ:PODD) from $370 to $350. The firm reiterated a Buy rating on the shares, with a revised upside of almost 45%.






